関連する実験動画
Updated: Jul 18, 2026

08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
肥満が糖尿病の原因になる方法: 壮大な話ではありません
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and The Penn Diabetes Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6149, USA. lazar@mail.med.upenn.edu
まとめ
肥満に関連した糖尿病は,増大する危機です. 機械学的研究は,脂肪分子と炎症が肥満と糖尿病を結びつけ,潜在的な治療目標を提供することを明らかにしています.
科学分野:
- 内分泌学と代謝について
- 分子生物学は分子生物学である.
- 進化医学とは,進化医学である.
背景:
- 肥満に関連した糖尿病は,世界的な健康危機を意味しています.
- 豊富な食べ物と身体活動の減少による現代的なライフスタイルは,この疫病を悪化させています.
- 生物学的基礎を理解することは,効果的な介入に不可欠です.
研究 の 目的:
- 肥満に関連した糖尿病の生物学的な基礎を探求する.
- 肥満と糖尿病の関係に関する進化論とメカニズム論の見方を見直す.
- メカニズム学的発見に基づいて潜在的な治療標的を特定する.
主な方法:
- "節約的な"遺伝子に関する進化論の見直し.
- 分子経路を調査するメカニズム学的研究の分析.
- 脂肪由来分子と炎症の役割の検討.
主要な成果:
- 進化論は興味深いものの,憶測的であり,検証が難しい.
- 機械学的研究により,多くの脂肪系分子が特定されています.
- これらの分子,炎症,肥満と糖尿病の間の重要な関連が明らかになりました.
結論:
- 脂肪由来分子と炎症の相互作用は,肥満に関連する糖尿病の重要な要因です.
- これらのメカニズム的な洞察は,治療開発のための有望な道を提供します.
- これらの経路に関するさらなる研究は,この広範な状態に対する新しい治療法につながる可能性があります.
関連する概念動画
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

